What is Evergreen Nephrology?
Evergreen Nephrology operates at the intersection of clinical excellence and administrative efficiency, specializing in the modernization of kidney care. By deploying a value-based care framework, the company empowers healthcare providers to move beyond traditional fee-for-service models, focusing instead on longitudinal health outcomes and patient-centric support. The platform integrates seamlessly with existing clinical workflows, providing actionable data that helps mitigate the barriers often associated with managing complex renal diseases. Through its collaborative approach, the company serves as a vital partner to payors and physicians, aiming to reduce the total cost of care while simultaneously improving the quality of life for patients navigating the challenges of kidney health.
How much funding has Evergreen Nephrology raised?
Evergreen Nephrology has raised a total of $130M across 1 funding round:
Other Financing Round
$130M
Other Financing Round (2025): $130M with participation from K2 HealthVentures, Rubicon, and Oak HC/FT
Key Investors in Evergreen Nephrology
K2 HealthVentures
K2 HealthVentures is an alternative investment firm providing flexible, long-term financing solutions to innovative companies within the life sciences and healthcare sectors.
Rubicon
Rubicon is a technology-driven firm specializing in software platforms and data analytics to optimize operational efficiency and sustainability across various industries.
Oak HC/FT
Oak HC/FT is a premier venture growth-equity fund focused on driving transformation within the healthcare information, services, and financial technology sectors.
What's next for Evergreen Nephrology?
Looking ahead, the strategic deployment of this recent financing will likely focus on expanding the company's geographic footprint and enhancing its proprietary data analytics capabilities. As the healthcare industry shifts toward more accountable care models, Evergreen Nephrology is poised to capitalize on the increasing demand for specialized, technology-enabled renal management solutions. The company's roadmap includes deepening its integration with primary care networks and refining its predictive modeling tools to identify high-risk patients earlier in the disease progression. By maintaining its focus on value-based outcomes, Evergreen Nephrology is set to remain a key disruptor in the nephrology sector, driving long-term sustainability for both providers and the patients they serve.
See full Evergreen Nephrology company page
